ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 405029 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 405029; 2) Community: the network communities that were significantly associated with the response to NSC 405029; 3) Molecule: the relationships between components within communities and NSC 405029; 4) MDR: the compounds that were significantly associated with the NSC 405029.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0385613993886001 0.082473971
NSC 18805 .gamma.-Thujaplicine 0.0385613993886001 0.31622205
NSC 23925 Null 0.0385613993886001 0.30012354
NSC 294961 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one 0.0385613993886001 0.089762677
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0385613993886001 0.18800128
NSC 321491 Null 0.0385613993886001 -0.23338615
NSC 331935 CHALCONE ANALOG 0.0385613993886001 0.27333245
NSC 606497 Camptothecin Derivative 0.0385613993886001 0.1669938
NSC 608329 Null 0.0385613993886001 -0.10758332
NSC 615534 Null 0.0385613993886001 -0.20488539
Total:64  Current:42    [First] [Prev] [Next] [Last]